CPHI vs CUBE
China Pharma Holdings Inc (CPHI) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
CPHI currently screens at market cap $29.0M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the CPHI and CUBE stock pages for the full models.
Not investment advice.